BARCLAY PHARMACEUTICALS LIMITED

Active Warwick

Wholesale of pharmaceutical goods

0 employees website.com
Wholesale of pharmaceutical goods
B

BARCLAY PHARMACEUTICALS LIMITED

Wholesale of pharmaceutical goods

Founded 3 Dec 1992 Active Warwick, England 0 employees website.com
Wholesale of pharmaceutical goods

Previous Company Names

SPEED 3150 LIMITED 3 Dec 1992 — 28 Jun 1993
Accounts Submitted 15 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 26 Jan 2026 Next due 8 Feb 2027 9 months remaining
Net assets £9M £18M 2024 year on year
Total assets £14M £14M 2024 year on year
Total Liabilities £5M £4M 2024 year on year
Charges 12
8 outstanding 4 satisfied

Contact & Details

Contact

Registered Address

The Woods Haywood Road Warwick CV34 5AH England

Website

www.example.com

Full company profile for BARCLAY PHARMACEUTICALS LIMITED (02770716), an active company based in Warwick, England. Incorporated 3 Dec 1992. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Net Assets

£9.14M

Decreased by £17.55M (-66%)

Total Liabilities

£4.57M

Increased by £3.91M (+597%)

Turnover

£66.42M

Increased by £2.76M (+4%)

Employees

N/A

Debt Ratio

33%

Increased by 31 (+1550%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Wendy Margaret HallDirectorBritishEngland5527 Jul 2022Active

Shareholders

Shareholders (2)

Aah Pharmaceuticals Limited
100.0%
25,000,000
Admenta Holdings Limited
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 25 Aug 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Admenta Holdings Limited

Ceased 25 Aug 2023

Ceased

Group Structure

Group Structure

AURELIUS FOX LIMITED united kingdom
ADMENTA UK LIMITED united kingdom
BARCLAY PHARMACEUTICALS LIMITED Current Company

Charges

Charges

8 outstanding 4 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Jan 2026Confirmation StatementConfirmation statement made on 2026-01-25 with no updates
15 Jan 2026OfficersAppointment of Mr Brian Gerard Chambers as director on 2025-12-22
8 Jan 2026OfficersAppointment of Mr Michael John Clark as director on 2025-12-22
2 Jan 2026OfficersTermination of David Jonathan Bound as director on 2025-12-26
15 Dec 2025AccountsAnnual accounts made up to 2025-03-31
26 Jan 2026 Confirmation Statement

Confirmation statement made on 2026-01-25 with no updates

15 Jan 2026 Officers

Appointment of Mr Brian Gerard Chambers as director on 2025-12-22

8 Jan 2026 Officers

Appointment of Mr Michael John Clark as director on 2025-12-22

2 Jan 2026 Officers

Termination of David Jonathan Bound as director on 2025-12-26

15 Dec 2025 Accounts

Annual accounts made up to 2025-03-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-01-25 with no updates

2 months ago on 26 Jan 2026

Appointment of Mr Brian Gerard Chambers as director on 2025-12-22

3 months ago on 15 Jan 2026

Appointment of Mr Michael John Clark as director on 2025-12-22

3 months ago on 8 Jan 2026

Termination of David Jonathan Bound as director on 2025-12-26

3 months ago on 2 Jan 2026

Annual accounts made up to 2025-03-31

4 months ago on 15 Dec 2025